Kei Endo

15PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Bioinformatic methods developmentPredictive and prognostic markersAutoimmunityMedical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 29, 2026
Atezolizumab Plus Bevacizumab Treatment for Patients With Hepatocellular Carcinoma in the Barcelona Clinic Liver Cancer B2 Stage.

|Jul 15, 2026
Prognostic performance of Asian Working Group for Sarcopenia 2019 and 2025 sarcopenia definitions in cirrhosis.

|Aug 23, 2025
Obesity Decreases Liver-Related Death in Patients With Cirrhosis: A Retrospective Propensity Score-Matched Study.

Kei Endo, Keisuke Kakisaka, Tamami Abe

|May 03, 2025
Autoimmune hepatitis following transition from prednisolone to thrombopoietin receptor agonist therapy in immune thrombocytopenic purpura: A clinical precaution.

Kaname Inarimori, Keisuke Kakisaka, Takuya Watanabe

|Oct 23, 2024
Body mass index of 23 or greater is relevant to hepatic steatosis and fibrosis in patients with harmful alcohol use.

Keisuke Kakisaka, Takuya Watanabe, Yuichi Yoshida

|Jun 15, 2024
Grip strength complements performance status in assessing general condition in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Kei Endo, Keisuke Kakisaka, Tamami Abe

Pageof 3

Frequent Collaborators

10 joint publications

Keisuke Kakisaka

9 joint publications

Akio Miyasaka

9 joint publications

Hidekatsu Kuroda

5 joint publications

Yuichi Yoshida